Jailed drug company founder Martin Shkreli worked to block rivals from introducing generic forms of an anti-parasite drug, the Federal Trade Commission and the New York attorney general allege in a new lawsuit
Jailed drug company founder Martin Shkreli and an associate violated competition laws by working to block rivals from introducing generic forms of an anti-parasite drug, the Federal Trade Commission and the New York attorney general have alleged in a new lawsuit.
The efforts by Mr. Shkreli to prevent competitors from producing generic versions of the drug, called Daraprim, continue to this day, the complaint filed Monday in federal court in New York says. Daraprim treats toxoplasmosis, a parasitic infection.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Authorities Seek Lifetime Ban For ‘Pharma Bro’ Martin Shkreli In New LawsuitNew York's attorney general and the FTC accuse Shkreli of allegedly impeding generic drugs from entering the market to preserve a monopoly.
Baca lebih lajut »
Authorities Seek Lifetime Ban For ‘Pharma Bro’ Martin Shkreli In New LawsuitNew York's attorney general and the FTC accuse Shkreli of allegedly impeding generic drugs from entering the market to preserve a monopoly.
Baca lebih lajut »
Ricky Martin, Bad Bunny, Becky G & More Latin Artists React to Kobe Bryant's DeathLatin music artists, such as Ricky Martin, Bad Bunny, and Becky G, react to Kobe Bryant's death.
Baca lebih lajut »
Authorities Seek Lifetime Ban For ‘Pharma Bro’ Martin Shkreli In New LawsuitNew York's attorney general and the FTC accuse Shkreli of allegedly impeding generic drugs from entering the market to preserve a monopoly.
Baca lebih lajut »
Authorities Seek Lifetime Ban For ‘Pharma Bro’ Martin Shkreli In New LawsuitNew York's attorney general and the FTC accuse Shkreli of allegedly impeding generic drugs from entering the market to preserve a monopoly.
Baca lebih lajut »